Related Articles
Statins improve survival in patients previously treated with nivolumab for advanced non‑small cell lung cancer: An observational study
Antibiotic use is a negative predictor of the efficacy and toxicity of epidermal growth factor receptor‑targeted therapy in advanced non‑small cell lung cancer
Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer
Role of combining neutrophil‑to‑lymphocyte ratio and pretreatment body mass index in predicting progression‑free survival in patients with non‑small cell lung cancer treated with nivolumab
Efficacy and safety of Nivolumab in non‑small cell lung cancer patients in Tel‑Aviv tertiary medical center: Facing the reality